Therapeutic Antibodies in HIV Treatment - Classical Approaches to Novel Advances

Abela, Irene A.; Reynell, Lucy; Trkola, Alexandra
November 2010
Current Pharmaceutical Design;11/28/2010, Vol. 16 Issue 33, p3754
Academic Journal
No abstract available.

Tags: HIV infections -- Treatment;  AIDS (Disease) -- Treatment;  MONOCLONAL antibodies;  IMMUNIZATION;  COMMUNICABLE diseases;  AUTOIMMUNE diseases;  MEDICINE, Preventive


Related Articles

  • Blockade of the CD154-CD40 costimulatory pathway prevents the development of experimental autoimmune glomerulonephritis. Reynolds, John; Khan, Sarah B.; Allen, Andrew R.; Benjamin, Christopher D.; Pusey, Charles D. // Kidney International;Oct2004, Vol. 66 Issue 4, p1444 

    Blockade of the CD154-CD40 costimulatory pathway prevents the development of experimental autoimmune glomerulonephritis.Background.Experimental autoimmune glomerulonephritis (EAG) was induced in Wistar-Kyoto (WKY) rats by immunization with rat glomerular basement membrane (GBM) in adjuvant. This...

  • Biological therapies directed against cells in autoimmune disease. Hasler, Paul // Springer Seminars in Immunopathology;Jun2006, Vol. 27 Issue 4, p443 

    Among the cells of the immune system involved in the pathogenesis of autoimmune disease, T cells have received the most attention. The central role of these cells in several animal models of autoimmune diseases and in human disease counterparts has provided the rationale for specific therapeutic...

  • Candidate Antibody-Based Therapeutics Against HIV-1. Rui Gong; Weizao Chen; Dimitrov, Dimiter S. // BioDrugs;2012, Vol. 26 Issue 3, p143 

    Antibody-based therapeutics have been successfully used for the treatment of various diseases and as research tools. Several well characterized, broadly neutralizing monoclonal antibodies (bnmAbs) targeting HIV-1 envelope glycoproteins or related host cell surface proteins show sterilizing...

  • Quality of Life of People Living with HIV/AIDS under the New Epidemic Characteristics in China and the Associated Factors Sun, Wei; Wu, Ming; Qu, Peng; Lu, Chunming; Wang, Lie // PLoS ONE;May2013, Vol. 8 Issue 5, p1 

    Background: Improvement of quality of life has been one of goals in health care for people living with HIV/AIDS (PLWHA). In China, the epidemic characteristics have changed and transmission is now most commonly sexual contact. However, the assessment of quality of life of PLWHA under new...

  • Drug news and trial developments.  // AIDS Patient Care & STDs;Mar1998, Vol. 12 Issue 3, p231 

    Presents information on drugs and trial developments in the treatment of human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS). AIDS vaccine study by VaxGen Incorporated; Study of HIV-positive patients receiving thalidomide treatment; Approval of rituximab for...

  • PHS proposes `parallel track' for new AIDS drugs.  // Public Health Reports;Sep/Oct90, Vol. 105 Issue 5, p541 

    Reports on the US Public Health Service's (PHS) proposal for speeding the availability of investigational new drugs for AIDS and HIV-related diseases by means of a parallel track mechanism. Selection of patients with life-threatening illnesses including AIDS; Views on the safeguards to parallel...

  • MCOs, AIDS activists join forces on national database for disease-management strategies.  // Managed Healthcare;Apr98, Vol. 8 Issue 4, p7 

    Reports on the HIV Treatment Data Project, a national database on HIV/AIDS treatments and disease-management being planned by the managed care industry and AIDS activists. Collaboration of the Group Health Cooperative Center for Health Studies and the University of Washington's Center for AIDS...

  • Glowing anecdotes have been told about every product sold to treat AIDS. Delaney, Martin // Advocate;10/23/90, Issue 562, p35 

    Reports on developments concerning treatment for HIV and AIDS as of October 23, 1990. Studies by Pauling Institute researchers focusing on the ability of vitamin C to fight HIV; Controversy over the use of oral alpha interferon for treatment of AIDS.

  • Massachusetts mandates AIDS drug coverage.  // Drug Topics;5/6/96, Vol. 140 Issue 9, p7 

    Reports that Massachusetts has become the first state to require health insurers to pay for certain drugs used off-label to treat HIV/AIDS patients.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics